FGF19 and colorectal carcinoma: This interplay between CRC cells and HSCs, along with the impact of the FGF19/ANGPTL4 axis on the severity of CRC liver metastasis, suggests a novel therapeutic strategy for treating CRC liver metastasis (Figure 7H).